Document is current

Article History

Received: 8 June 2023

Revised: 16 August 2023

Accepted: 17 August 2023

First Online: 24 August 2023

Declarations

:

: On behalf of all authors, the corresponding author states that there is no conflict of interest. Financial disclosures: The Radboudumc Center of Expertise for Parkinson’s & Movement Disorders is supported by a center of excellence grant of the Parkinson’s Foundation. AW and AS: no additional disclosures to report. BB: currently serves as co-Editor in Chief for the <i>Journal of Parkinson’s disease</i> and serves on the editorial board of <i>Practical Neurology</i> and <i>Digital Biomarkers</i>, has received honoraria from serving on the scientific advisory board for Abbvie, Biogen, and UCB, has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial, and has received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, UCB, Not Impossible, the Hersenstichting Nederland, the Parkinson’s Foundation, Verily Life Sciences, Horizon 2020 and the Parkinson Vereniging (all paid to the institute).

: Written informed consent was obtained from the patient. The participant has consented to the submission of the case report to the journal. The authors confirm that the approval of the institutional review board was not required for this work. We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.

: All authors had full access to the data in the case report and had final responsibility for the decision to submit for publication.